Related references
Note: Only part of the references are listed.Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis
W. Hanel et al.
CELL DEATH AND DIFFERENTIATION (2013)
Network Analysis Identifies an HSP90-Central Hub Susceptible in Ovarian Cancer
Hanqing Liu et al.
CLINICAL CANCER RESEARCH (2013)
Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53
Xiangbing Meng et al.
GYNECOLOGIC ONCOLOGY (2013)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance
Heidi Sankala et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
Javier E. Girardini et al.
CANCER CELL (2011)
MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF
Chang-Il Hwang et al.
CELL CYCLE (2011)
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
D. Li et al.
CELL DEATH AND DIFFERENTIATION (2011)
TopBP1 Mediates Mutant p53 Gain of Function through NF-Y and p63/p73
Kang Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells
Kazuhito Yoshikawa et al.
BIOMEDICAL RESEARCH-TOKYO (2010)
Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
Perry Stambolsky et al.
CANCER CELL (2010)
Mutant p53-induced Up-regulation of Mitogen-activated Protein Kinase Kinase 3 Contributes to Gain of Function
Aymone Gurtner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Characterization of Functional Domains Necessary for Mutant p53 Gain of Function
Wensheng Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A common gain of function of p53 cancer mutants in inducing genetic instability
D. P. Liu et al.
ONCOGENE (2010)
Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
G. Hofstetter et al.
ONCOGENE (2010)
Mouse Models of p53 Functions
Guillermina Lozano
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53
Sue Haupt et al.
CANCER RESEARCH (2009)
Mutant p53 Drives Invasion by Promoting Integrin Recycling
Patricia A. J. Muller et al.
CELL (2009)
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Maddalena Adorno et al.
CELL (2009)
Identification of GRO1 as a Critical Determinant for Mutant p53 Gain of Function
Wensheng Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway
Peixin Dong et al.
MOLECULAR CANCER (2009)
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
Giulia Fontemaggi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Structural evolution of p53, p63, and p73: Implication for heterotetramer formation
Andreas C. Joerger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
20 years studying p53 functions in genetically engineered mice
Lawrence A. Donehower et al.
NATURE REVIEWS CANCER (2009)
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy
Gianluca Bossi et al.
CELL CYCLE (2008)
The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs
Silvia Di Agostino et al.
CELL CYCLE (2008)
The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo
Ming Kei Lee et al.
JOURNAL OF CELL SCIENCE (2008)
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
Frank M. Boeckler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Protumorigenic overexpression of Stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis
Stephan Singer et al.
HEPATOLOGY (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Hoseok Song et al.
NATURE CELL BIOLOGY (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Modeling the therapeutic efficacy of p53 restoration in tumors
Carla P. Martins et al.
CELL (2006)
Structural basis for understanding oncogenic p53 mutations and designing rescue drugs
Andreas C. Joerger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
Tumor-derived p53 mutants induce NF-κB2 gene expression
MJ Scian et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Direct p53 transcriptional repression:: In vivo analysis of CCAAT-containing G2/M promoters
C Imbriano et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
被撤回的出版物: Transactivation of the EGR1 gene contributes to mutant p53 gain of function (Retracted article. See vol. 79, pg. 2085, 2019)
L Weisz et al.
CANCER RESEARCH (2004)
Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line
KT Chan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes
MJ Scian et al.
ONCOGENE (2004)
P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer
RAM Sagarra et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)
Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: A Southwest Oncology Group ancillary study
D Hawes et al.
GYNECOLOGIC ONCOLOGY (2002)
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer
RE Buller et al.
CANCER GENE THERAPY (2002)
Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500
RE Buller et al.
CANCER GENE THERAPY (2002)
Does p53 affect organismal aging?
LA Donehower
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Physical interaction with human tumor-derived p53 mutants inhibits p63 activities
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization
YH Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells
FL Chang et al.
JOURNAL OF UROLOGY (2001)
Stabilization of the MDM2 oncoprotein by mutant p53
YH Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C
A Torgeman et al.
VIROLOGY (2001)
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
C Gaiddon et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Mutant p53 forms a complex with Sp1 on HIV-LTR DNA
A Chicas et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Physical and functional interaction between p53 mutants and different isoforms of p73
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
High metastatic potential in mice inheriting a targeted p53 missense mutation
G Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts
KP Magnusson et al.
GENE (2000)
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
MC Marin et al.
NATURE GENETICS (2000)
Share Paper
